HYPERLIQUID STRATEGIES INC (PURR)
NASDAQFinancialsFinancial - Capital MarketsSnapshot 2026-10-23
$8.78+1.15%
Close 2026-10-23 · 1-day change
NASDAQFinancialsFinancial - Capital MarketsSnapshot 2026-10-23
Research Workspace
Put PURR beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Investment Banking & Brokerage is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisModerate volatility — typically moves about 3% a day.
View RiskNot enough reads yet
PURR's HYPE treasury must keep expanding through disciplined capital deployment. The latest recorded quarter missed sharply, with a 47% next-quarter miss probability. No revenue growth rate is available to confirm the growth trajectory. A clean valuation multiple is unavailable, so peer multiples cannot define the price. The price is roughly in line with forecast growth, but Mania raises risk. PURR's 38% drop from its recent high flags possible thesis repricing. A further miss could pressure estimates after the past quarter's large miss. Peer multiples imply a price about 43% above where it trades. Our standing thesis remains intact; this read is provisional.
Trailing returns as of 2026-10-23. PURR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 4 analysts currently covering PURR (as of Oct 2026).
Based on 3 Wall Street analysts offering 12-month price targets for PURR in the last 4 months.
Continue this research
Compare PURR with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| PURR Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 2 valuation methods, at three horizons. As of 2026-10-23. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Investment Banking & Brokerage — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put PURR next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand HYPE token treasury and capital deployment
Demonstrates success in expanding HYPE token treasury.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-23. EPS is implied from price ÷ P/E. Not investment advice.
Current $8.78
The last 12 months of price, then the range of analyst 12-month targets from today’s $8.78.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Analyst buy rating supports positive sentiment for the stock.
Advances: Maintain disciplined capital deployment and equity management
Amendment may enhance capital deployment discipline.
Advances: Expand HYPE token treasury and capital deployment
Increases focus on HYPE and buybacks aligns with growth.
Advances: Expand HYPE token treasury and capital deployment
Significant HYPE position enhances treasury and growth.
Advances: Expand HYPE token treasury and capital deployment
Trump's support enhances regulatory outlook for HYPE token.
Significant price drop may affect capital deployment plans.